ArticleBriefings in bioinformatics2026
DDTRN: predicting bacterial transcriptional regulatory networks based on gene sequences using dual descriptor.
Article in Briefings in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Accurate computational reconstruction of bacterial transcriptional regulatory network (TRN) remains a fundamental challenge in systems biology, particularly for non-model organisms lacking extensive transcriptomic data. We present DDTRN, a sequence-driven framework that formulates TRN inference as a binary classification task over concatenated regulator-target gene sequence pairs and employs a Dual Descriptor (DD) model to predict regulatory interactions. The DD architecture represents a sequence using two learnable components: Composition Weight Map (CWM) and Position Weight Function (PWF). We comprehensively evaluate DDTRN against six conventional machine learning (ML) baselines across eight benchmark bacterial datasets, including Escherichia coli (DREAM5, RegulonDB), Bacillus subtilis, Salmonella enterica, Corynebacterium glutamicum, Mycobacterium tuberculosis, Pseudomonas aeruginosa, and Streptomyces coelicolor. DDTRN achieves superior overall performance, attaining average area under the receiver operating characteristic curve and area under the precision-recall curve scores of 0.869 and 0.868, respectively, with particularly pronounced advantages at lower descriptor ranks where positional weighting compensates for limited sequence context. Systematic sensitivity analyses of rank, embedding dimension, and basis function count reveal stable optimal operating regimes, while subsampling experiments demonstrate strong robustness even with limited training data. Interpretability analyses show that PWF learns distinct periodic contributions across different rank granularities and that CWM preferentially weights meaningful k-mers. A case study on the E. coli dataset further illustrates that DDTRN identifies method-specific candidate targets complementary to those proposed by conventional approaches. By operating solely on genomic sequence, DDTRN provides a scalable, interpretable, and data-efficient framework for bacterial TRN inference in species where expression data are scarce, and it establishes a foundation for future multimodal integration with condition-specific regulatory information.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.